martes, 6 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 12, 2026

Citigroup Q4 Earnings on the Deck: How to Approach the Stock Now?

View original at finance.yahoo.com
Citigroup Q4 Earnings on the Deck: How to Approach the Stock Now? Citigroup Inc. C is slated to report fourth-quarter and full-year 2025 results on Jan…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Management expects NII (excluding Markets) to rise 5.5% on a year-over-year basis

    80% confidence
  • Citigroup expects market revenues to be down in the low to mid-single digit in the fourth quarter from a year ago

    80% confidence
  • Citigroup expects revenues to cross $84 billion compared with the prior mentioned $84.1 billion

    80% confidence
  • The transaction is expected to result in a pre-tax loss of $1.2 billion in the fourth quarter of 2025

    80% confidence
  • Management anticipates expenses to be higher than $53.4 billion, including the impacts of FX translation and excluding the goodwill impairment

    80% confidence
  • The company is seeing continued momentum, particularly in M&A

    80% confidence
  • Branded Cards net credit loss (NCL) is expected to be 3.50-4%

    80% confidence
  • Retail Services NCL is expected to be 5.75-6.25%

    80% confidence
  • Its earnings outpaced the Zacks Consensus Estimate in the trailing four quarters, the average surprise being 13.19%

    80% confidence
  • The Zacks Consensus Estimate for fourth-quarter sales is pegged at $20.94 billion, indicating a 6.9% year-over-year increase

    80% confidence
  • The efficiency ratio is expected to be slightly less than 64%

    80% confidence
  • The consensus estimate for earnings for the to-be-reported quarter has been revised downward to $1.65 over the past seven days, indicating a 23.1% rise from the prior-year quarter's actual

    80% confidence
  • Management expects IB fees to increase in the mid-20s (percentage) year over year in the fourth quarter

    80% confidence

Data points we hold from this source

Citigroup Inc. · forward pe ratio11.92 ratio
Citigroup Inc. · non accrual loans3.7 billion_USD
Citigroup Inc. · principal transactions income2.1 billion_USD
Citigroup Inc. · efficiency ratio64 percent
Citigroup Inc. · revenue20.94 billion_USD
Citigroup Inc. · revenue84 billion_USD
Citigroup Inc. · average interest earning assets2.5 trillion_USD
Citigroup Inc. · commissions and fees2.9 billion_USD
Citigroup Inc. · market revenue4.5 billion_USD
Citigroup Inc. · net interest income14.9 billion_USD
Citigroup Inc. · non interest income5.9 billion_USD
Citigroup Inc. · administration and fiduciary fees1.0 billion_USD
Citigroup Inc. · stock repurchase authorization remaining11.3 billion_USD
Citigroup Inc. · dividend per share0.60 USD
Board of Governors of the Federal Reserve System · fed funds rate3.50-3.75 percent
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com
Citigroup Q4 Earnings on the Deck: How to Approach the Stock Now? — Source | Via News | es.VIA.NEWS